Evaluation of 2D-shear wave elastography for characterisation of focal liver lesions running title: 2D-SWE and liver lesions

Purpose: The aim of this prospective study was to evaluate 2D-shear-wave-elastography (2D-SWE) for characterisation and differentiation of benign and malignant focal liver lesions (FLLs). Material & methods: Patients referred to our ultrasound unit for surveillance of chronic liver disease or wo...

Full description

Saved in:
Bibliographic Details
Published inUltraschall in der Medizin - European Journal of Ultrasound
Main Authors Fitting, D, Gerber, L, Srikantharajah, K, Luhne, S, Klein, S, Weiler, N, Kyriakidou, G, Bojunga, JB, Hansmann, ML, Bon, D, Albert, J, Zeuzem, S, Friedrich-Rust, M
Format Conference Proceeding
LanguageEnglish
German
Published 18.08.2016
Online AccessGet full text

Cover

Loading…
More Information
Summary:Purpose: The aim of this prospective study was to evaluate 2D-shear-wave-elastography (2D-SWE) for characterisation and differentiation of benign and malignant focal liver lesions (FLLs). Material & methods: Patients referred to our ultrasound unit for surveillance of chronic liver disease or work-up of incidentally detected FLLs were prospectively included. B-mode ultrasound and 2D-SWE (Aixplorer® France) was performed for one FLL in each patient. Liver histology obtained by biopsy and/or contrast-enhanced imaging was used as reference method. The Mann-Whitney and Kruskal-Wallis test was used to assess the stiffness difference between the groups. Results: 140 patients with FLL were included. SWE acquisitions failed in 34 FLLs (24%). Therefore, 106 patients with FLL could be analysed, 42/106 (40%) with benign and 64/106 (60%) with malignant FLLs. 58/106 (55%) FFLs were localized in the right liver lobe. The median stiffness for benign FLLs was 16.4 (2.1 – 71.9) kPa (in detail: 16.55 kPa for 18 focal nodular hyperplasia (FNH), 16.35 kPa for 18 hemangioma, 9.8 kPa for 3 focal fatty sparings (FFS), 8.9 kPa for 1 adenoma, 20 kPa for one regenerative node and 29 kPa for one cholangiofibroma) and for the malignant FLLs 36 (4.1 – 142.9) kPa (in detail: 44.8 kPa for 16 hepatocellular carcinoma (HCC), 70.7 kPa for 7 cholangiocarcinoma (CCC) and 29.5 kPa for the 41 metastasis) (p < 0.001). Malignant FLLs were significantly stiffer than benign FLLs (p < 0.0001). CCCs were the stiffest malignant FFLs with significantly higher values as compared to HCCs and metastases (p = 0.033 and p = 0.0079). No significant difference in stiffness could be observed between the different benign FLL entities. No significant difference was observed whether 2D-SWE included the whole FLL, only the periphery or only the hardest area of the FLL. Conclusions: 2D-SWE provides further characterising information for interpretation of FLLs and may be useful at least in differentiation of CCCs and HCCs.
ISSN:0172-4614
1438-8782
DOI:10.1055/s-0036-1587745